Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: Can they predict treatment response and clinical outcome?

Human Pathology

Volumn 30, Issue 11, 1999, Pages 1367-1372

  Feinmesser, Meora ^a   Halpern, Marisa ^b   Fenig, Eyal ^b   Tsabari, Cohava ^b   Hodak, Emmilia ^b   Sulkes, Jaqueline ^b   Brenner, Baruch ^b   Okon, Elimelech ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Apoptosis; Merkel cell carcinoma; Proapoptotic and antiapoptotic genes; Treatment

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RECURRENCE; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; MERKEL CELL TUMOR; TUMOR GROWTH; TUMOR VOLUME;

EID: 0032745541     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90070-9     Document Type: Article

References (35)

1. Boyle F, Pendlebury S, Bell D: Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 31:315-323, 1995
2. Takes RP, Balm AJM, Loftus BM, et al: Merkel cell carcinoma of the head and neck. Clin Otolaryngol 19:222-229, 1994
3. Ratner D, Nelson BR, Brown MO, et al: Merkel cell carcinoma. J Am Acad Dermatol 29:143-156, 1993
4. Hitchcock CL, Bland KI, Laney RG: Neuroendocrine (Merkel cell) carcinoma of the skin: Ann Surg 207:201-207, 1988
5. Goepfert H, Remmler De Silva E, et al: Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol 110:707-712, 1984
6. Smith DE, Bielamowicz S, Kagan AR: Cutaneous neuroendocrine (Merkel cell) carcinoma. Am J Clin Oncol 18:199-203, 1995
7. Meeuwissen JA, Bourne RG, Kearsley JH: The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiation Oncol Biol Phys 31:325-331, 1995
8. Fenig E, Lurie H, Sulkes A: The use of cycloheximide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol 16:54-57, 1993
9. Kerr JFR, Winterford CM, Harmon BV: Apoptosis: Its significance in cancer and cancer therapy. Cancer 73:2013-2026, 1994
10. Stephens LC, Ang KK, Schultheiss TE, et al: Apoptosis in irradiated murine tumors. Radiat Res 127:308-316, 1991
11. Sugamura K, Makino M, Shirai H, et al: Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil. Cancer 79:12-17, 1997
12. Findley HW, Lubing G, Yeager AM, et al: Expression and regulation of Bcl-2, Bcl-xl and bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 89:2986-2993, 1997
13. Krajewski S, Blomqvist C, Franssila K, et al: Reduced expression of proapoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55:4471-4478, 1995
14. Sakakura C, Sweeney EA, Shirahama T, et al: Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 67:101-105, 1996
15. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-157, 1993
16. Miyashita T, Reed JC: bcl-2 gene transfer increases relative resistance of S49.1 and WEH 17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52:5407-5411, 1992
17. Lowe SW, Ruley HE, Jacks T, et al: p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967, 1993
18. Bargou RC, Daniel PT, Mapara MY, et al: Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-α expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 60:854-859, 1995
19. Fenig E, Brenner B, Katz A, et al: The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 80:881-885, 1997
20. Gould VE, Moll R, Moll I, et al: Biology of disease: Neuroendocrine (Merkel) cells of the skin: Hyperplasias, dysplasias and neoplasms. Lab Invest 52:334-353, 1985
21. Krajewska M, Krajewski S, Epstein IE, et al: Immunohistochemical analysis of bcl-2, bax, bcl-x and mcl-1 expression in prostate cancers. Am J Pathol 148:1567-1576, 1996
22. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6, 1994
23. Tsujimoto Y, Croce CM: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A 83:5214-5218, 1986
24. Oltvai ZN, Milliman C, Korsmeyer S: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619, 1993
25. Korsmeyer SJ: Bcl-2: An antidote to programmed cell death. Cancer Surveys 15:105-118, 1992
26. Yin XM, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 369:321-323, 1994
27. Harris CC: Structure and function of the p53 tumor suppressor gene: Clues for rationale cancer therapeutic strategies. J Natl Cancer Inst 88:1442-1455, 1996
28. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 80:293-299, 1995
29. Miyashita T, Krajewski S, Krajewska M, et al: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805, 1995
30. Schmid M, Janben K, Dockhorn-Dworniczak B, et al: p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. Virchows Arch 430:233-237, 1997
31. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins. Science 248:76-79, 1990
32. Campbell C, Quinn AG, Angus B, et al: Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res 53:2697-2699, 1993
33. Moll I, Gillardon F, Waltering S, et al: Differences of bcl-2 protein expression between Merkel cells and Merkel cell carcinomas. J Cutan Pathol 23:109-117, 1996
34. Reed JC: Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9:451-474, 1995
35. Kennedy MM, Blessing K, King G, et al: Expression of bcl-2 and p53 in Merkel cell carcinoma. Am J Dermatol Pathol 18:273-277, 1996